Loading…

Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy

Disruption in DNA methylation processes can lead to alteration in gene expression and function that would ultimately result in malignant transformation. In this way, studies have shown that, in cancers, methylation-associated silencing inactivates tumor suppressor genes, as effectively as mutations....

Full description

Saved in:
Bibliographic Details
Published in:Cancer gene therapy 2021-04, Vol.28 (3-4), p.157-174
Main Authors: Karimzadeh, Mohammad Reza, Pourdavoud, Peyman, Ehtesham, Naeim, Qadbeigi, Mohaddese, Asl, Masood Movahedi, Alani, Behrang, Mosallaei, Meysam, Pakzad, Bahram
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c539t-1e0e83fcab60b44d1e3e2b6770508774539c9187613953d8bd6f21892f8bced23
cites cdi_FETCH-LOGICAL-c539t-1e0e83fcab60b44d1e3e2b6770508774539c9187613953d8bd6f21892f8bced23
container_end_page 174
container_issue 3-4
container_start_page 157
container_title Cancer gene therapy
container_volume 28
creator Karimzadeh, Mohammad Reza
Pourdavoud, Peyman
Ehtesham, Naeim
Qadbeigi, Mohaddese
Asl, Masood Movahedi
Alani, Behrang
Mosallaei, Meysam
Pakzad, Bahram
description Disruption in DNA methylation processes can lead to alteration in gene expression and function that would ultimately result in malignant transformation. In this way, studies have shown that, in cancers, methylation-associated silencing inactivates tumor suppressor genes, as effectively as mutations. DNA methylation machinery is composed of several genes, including those with DNA methyltransferases activity, proteins that bind to methylated cytosine in the promoter region, and enzymes with demethylase activity. Based on a prominent body of evidence, DNA methylation machinery could be regulated by microRNAs (miRNAs) called epi-miRNAs. Numerous studies demonstrated that dysregulation in DNA methylation regulators like upstream epi-miRNAs is indispensable for carcinogenesis; consequently, the malignant capacity of these cells could be reversed by restoring of this regulatory system in cancer. Conceivably, recognition of these epi-miRNAs in cancer cells could not only reveal novel molecular entities in carcinogenesis, but also render promising targets for cancer therapy. In this review, at first, we have an overview of the methylation alteration in cancers, and the effect of this phenomenon in miRNAs expression and after that, we conduct an in-depth discussion about the regulation of DNA methylation regulators by epi-miRNAs in cancer cells.
doi_str_mv 10.1038/s41417-020-00210-7
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2515480002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A659115923</galeid><sourcerecordid>A659115923</sourcerecordid><originalsourceid>FETCH-LOGICAL-c539t-1e0e83fcab60b44d1e3e2b6770508774539c9187613953d8bd6f21892f8bced23</originalsourceid><addsrcrecordid>eNp9kdFr1TAUxoMo7jr9B3yQgOBb50nSNq1vl7mpMCYMfQ5petpmNOk1aZH-92br1TkQycOB8_2-E875CHnN4IyBqN7HnOVMZsAhA-AMMvmE7Fguy6woAJ6SHdS8zlgN4oS8iPEWIIlSPCcngqcqZbkj7gb7ZdSznTydOvrxek8dzsN6bDltBusxrLRZKR5s5uzN9T5S6-mwOO2p0d5g-EDRYeit76nHn3TWocf5ntp0Og8Y9GF9SZ51eoz46lhPyffLi2_nn7Orr5--nO-vMlOIes4YAlaiM7opocnzlqFA3pRSQgGVlHmCTM0qWTJRF6KtmrbsOKtq3lWNwZaLU_J2m3sI048F46xupyX49KXiBSvyCtLBHqhej6is76Y5aONsNGpfFjVjRc1Fos7-QaXXorNm8tjZ1H9kePeXYUA9zkOcxuXuoPExyDfQhCnGgJ06BOt0WBUDdZew2hJWKWF1n7CSyfTmuNrSOGz_WH5HmgCxATFJvsfwsPt_xv4Ck-qt6w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2515480002</pqid></control><display><type>article</type><title>Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy</title><source>Springer Nature</source><creator>Karimzadeh, Mohammad Reza ; Pourdavoud, Peyman ; Ehtesham, Naeim ; Qadbeigi, Mohaddese ; Asl, Masood Movahedi ; Alani, Behrang ; Mosallaei, Meysam ; Pakzad, Bahram</creator><creatorcontrib>Karimzadeh, Mohammad Reza ; Pourdavoud, Peyman ; Ehtesham, Naeim ; Qadbeigi, Mohaddese ; Asl, Masood Movahedi ; Alani, Behrang ; Mosallaei, Meysam ; Pakzad, Bahram</creatorcontrib><description>Disruption in DNA methylation processes can lead to alteration in gene expression and function that would ultimately result in malignant transformation. In this way, studies have shown that, in cancers, methylation-associated silencing inactivates tumor suppressor genes, as effectively as mutations. DNA methylation machinery is composed of several genes, including those with DNA methyltransferases activity, proteins that bind to methylated cytosine in the promoter region, and enzymes with demethylase activity. Based on a prominent body of evidence, DNA methylation machinery could be regulated by microRNAs (miRNAs) called epi-miRNAs. Numerous studies demonstrated that dysregulation in DNA methylation regulators like upstream epi-miRNAs is indispensable for carcinogenesis; consequently, the malignant capacity of these cells could be reversed by restoring of this regulatory system in cancer. Conceivably, recognition of these epi-miRNAs in cancer cells could not only reveal novel molecular entities in carcinogenesis, but also render promising targets for cancer therapy. In this review, at first, we have an overview of the methylation alteration in cancers, and the effect of this phenomenon in miRNAs expression and after that, we conduct an in-depth discussion about the regulation of DNA methylation regulators by epi-miRNAs in cancer cells.</description><identifier>ISSN: 0929-1903</identifier><identifier>EISSN: 1476-5500</identifier><identifier>DOI: 10.1038/s41417-020-00210-7</identifier><identifier>PMID: 32773776</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>13/2 ; 13/89 ; 631/67/68 ; 692/699/67 ; Biomedical and Life Sciences ; Biomedicine ; Cancer ; Cancer cells ; Cancer therapies ; Carcinogenesis ; Care and treatment ; Cytosine ; Deoxyribonucleic acid ; DNA ; DNA Methylation ; Gene Expression ; Gene Therapy ; Genetic aspects ; Genetic regulation ; Health aspects ; Humans ; Methylation ; Methyltransferases ; MicroRNA ; MicroRNAs - genetics ; miRNA ; Neoplasms - genetics ; Neoplasms - therapy ; Oncology, Experimental ; Review Article ; Tumor suppressor genes</subject><ispartof>Cancer gene therapy, 2021-04, Vol.28 (3-4), p.157-174</ispartof><rights>The Author(s), under exclusive licence to Springer Nature America, Inc. 2020</rights><rights>COPYRIGHT 2021 Nature Publishing Group</rights><rights>The Author(s), under exclusive licence to Springer Nature America, Inc. 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c539t-1e0e83fcab60b44d1e3e2b6770508774539c9187613953d8bd6f21892f8bced23</citedby><cites>FETCH-LOGICAL-c539t-1e0e83fcab60b44d1e3e2b6770508774539c9187613953d8bd6f21892f8bced23</cites><orcidid>0000-0003-1496-4014</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32773776$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Karimzadeh, Mohammad Reza</creatorcontrib><creatorcontrib>Pourdavoud, Peyman</creatorcontrib><creatorcontrib>Ehtesham, Naeim</creatorcontrib><creatorcontrib>Qadbeigi, Mohaddese</creatorcontrib><creatorcontrib>Asl, Masood Movahedi</creatorcontrib><creatorcontrib>Alani, Behrang</creatorcontrib><creatorcontrib>Mosallaei, Meysam</creatorcontrib><creatorcontrib>Pakzad, Bahram</creatorcontrib><title>Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy</title><title>Cancer gene therapy</title><addtitle>Cancer Gene Ther</addtitle><addtitle>Cancer Gene Ther</addtitle><description>Disruption in DNA methylation processes can lead to alteration in gene expression and function that would ultimately result in malignant transformation. In this way, studies have shown that, in cancers, methylation-associated silencing inactivates tumor suppressor genes, as effectively as mutations. DNA methylation machinery is composed of several genes, including those with DNA methyltransferases activity, proteins that bind to methylated cytosine in the promoter region, and enzymes with demethylase activity. Based on a prominent body of evidence, DNA methylation machinery could be regulated by microRNAs (miRNAs) called epi-miRNAs. Numerous studies demonstrated that dysregulation in DNA methylation regulators like upstream epi-miRNAs is indispensable for carcinogenesis; consequently, the malignant capacity of these cells could be reversed by restoring of this regulatory system in cancer. Conceivably, recognition of these epi-miRNAs in cancer cells could not only reveal novel molecular entities in carcinogenesis, but also render promising targets for cancer therapy. In this review, at first, we have an overview of the methylation alteration in cancers, and the effect of this phenomenon in miRNAs expression and after that, we conduct an in-depth discussion about the regulation of DNA methylation regulators by epi-miRNAs in cancer cells.</description><subject>13/2</subject><subject>13/89</subject><subject>631/67/68</subject><subject>692/699/67</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer</subject><subject>Cancer cells</subject><subject>Cancer therapies</subject><subject>Carcinogenesis</subject><subject>Care and treatment</subject><subject>Cytosine</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA Methylation</subject><subject>Gene Expression</subject><subject>Gene Therapy</subject><subject>Genetic aspects</subject><subject>Genetic regulation</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Methylation</subject><subject>Methyltransferases</subject><subject>MicroRNA</subject><subject>MicroRNAs - genetics</subject><subject>miRNA</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - therapy</subject><subject>Oncology, Experimental</subject><subject>Review Article</subject><subject>Tumor suppressor genes</subject><issn>0929-1903</issn><issn>1476-5500</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kdFr1TAUxoMo7jr9B3yQgOBb50nSNq1vl7mpMCYMfQ5petpmNOk1aZH-92br1TkQycOB8_2-E875CHnN4IyBqN7HnOVMZsAhA-AMMvmE7Fguy6woAJ6SHdS8zlgN4oS8iPEWIIlSPCcngqcqZbkj7gb7ZdSznTydOvrxek8dzsN6bDltBusxrLRZKR5s5uzN9T5S6-mwOO2p0d5g-EDRYeit76nHn3TWocf5ntp0Og8Y9GF9SZ51eoz46lhPyffLi2_nn7Orr5--nO-vMlOIes4YAlaiM7opocnzlqFA3pRSQgGVlHmCTM0qWTJRF6KtmrbsOKtq3lWNwZaLU_J2m3sI048F46xupyX49KXiBSvyCtLBHqhej6is76Y5aONsNGpfFjVjRc1Fos7-QaXXorNm8tjZ1H9kePeXYUA9zkOcxuXuoPExyDfQhCnGgJ06BOt0WBUDdZew2hJWKWF1n7CSyfTmuNrSOGz_WH5HmgCxATFJvsfwsPt_xv4Ck-qt6w</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Karimzadeh, Mohammad Reza</creator><creator>Pourdavoud, Peyman</creator><creator>Ehtesham, Naeim</creator><creator>Qadbeigi, Mohaddese</creator><creator>Asl, Masood Movahedi</creator><creator>Alani, Behrang</creator><creator>Mosallaei, Meysam</creator><creator>Pakzad, Bahram</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><orcidid>https://orcid.org/0000-0003-1496-4014</orcidid></search><sort><creationdate>20210401</creationdate><title>Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy</title><author>Karimzadeh, Mohammad Reza ; Pourdavoud, Peyman ; Ehtesham, Naeim ; Qadbeigi, Mohaddese ; Asl, Masood Movahedi ; Alani, Behrang ; Mosallaei, Meysam ; Pakzad, Bahram</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c539t-1e0e83fcab60b44d1e3e2b6770508774539c9187613953d8bd6f21892f8bced23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>13/2</topic><topic>13/89</topic><topic>631/67/68</topic><topic>692/699/67</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer</topic><topic>Cancer cells</topic><topic>Cancer therapies</topic><topic>Carcinogenesis</topic><topic>Care and treatment</topic><topic>Cytosine</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA Methylation</topic><topic>Gene Expression</topic><topic>Gene Therapy</topic><topic>Genetic aspects</topic><topic>Genetic regulation</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Methylation</topic><topic>Methyltransferases</topic><topic>MicroRNA</topic><topic>MicroRNAs - genetics</topic><topic>miRNA</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - therapy</topic><topic>Oncology, Experimental</topic><topic>Review Article</topic><topic>Tumor suppressor genes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karimzadeh, Mohammad Reza</creatorcontrib><creatorcontrib>Pourdavoud, Peyman</creatorcontrib><creatorcontrib>Ehtesham, Naeim</creatorcontrib><creatorcontrib>Qadbeigi, Mohaddese</creatorcontrib><creatorcontrib>Asl, Masood Movahedi</creatorcontrib><creatorcontrib>Alani, Behrang</creatorcontrib><creatorcontrib>Mosallaei, Meysam</creatorcontrib><creatorcontrib>Pakzad, Bahram</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><jtitle>Cancer gene therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karimzadeh, Mohammad Reza</au><au>Pourdavoud, Peyman</au><au>Ehtesham, Naeim</au><au>Qadbeigi, Mohaddese</au><au>Asl, Masood Movahedi</au><au>Alani, Behrang</au><au>Mosallaei, Meysam</au><au>Pakzad, Bahram</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy</atitle><jtitle>Cancer gene therapy</jtitle><stitle>Cancer Gene Ther</stitle><addtitle>Cancer Gene Ther</addtitle><date>2021-04-01</date><risdate>2021</risdate><volume>28</volume><issue>3-4</issue><spage>157</spage><epage>174</epage><pages>157-174</pages><issn>0929-1903</issn><eissn>1476-5500</eissn><abstract>Disruption in DNA methylation processes can lead to alteration in gene expression and function that would ultimately result in malignant transformation. In this way, studies have shown that, in cancers, methylation-associated silencing inactivates tumor suppressor genes, as effectively as mutations. DNA methylation machinery is composed of several genes, including those with DNA methyltransferases activity, proteins that bind to methylated cytosine in the promoter region, and enzymes with demethylase activity. Based on a prominent body of evidence, DNA methylation machinery could be regulated by microRNAs (miRNAs) called epi-miRNAs. Numerous studies demonstrated that dysregulation in DNA methylation regulators like upstream epi-miRNAs is indispensable for carcinogenesis; consequently, the malignant capacity of these cells could be reversed by restoring of this regulatory system in cancer. Conceivably, recognition of these epi-miRNAs in cancer cells could not only reveal novel molecular entities in carcinogenesis, but also render promising targets for cancer therapy. In this review, at first, we have an overview of the methylation alteration in cancers, and the effect of this phenomenon in miRNAs expression and after that, we conduct an in-depth discussion about the regulation of DNA methylation regulators by epi-miRNAs in cancer cells.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>32773776</pmid><doi>10.1038/s41417-020-00210-7</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0003-1496-4014</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0929-1903
ispartof Cancer gene therapy, 2021-04, Vol.28 (3-4), p.157-174
issn 0929-1903
1476-5500
language eng
recordid cdi_proquest_journals_2515480002
source Springer Nature
subjects 13/2
13/89
631/67/68
692/699/67
Biomedical and Life Sciences
Biomedicine
Cancer
Cancer cells
Cancer therapies
Carcinogenesis
Care and treatment
Cytosine
Deoxyribonucleic acid
DNA
DNA Methylation
Gene Expression
Gene Therapy
Genetic aspects
Genetic regulation
Health aspects
Humans
Methylation
Methyltransferases
MicroRNA
MicroRNAs - genetics
miRNA
Neoplasms - genetics
Neoplasms - therapy
Oncology, Experimental
Review Article
Tumor suppressor genes
title Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A36%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulation%20of%20DNA%20methylation%20machinery%20by%20epi-miRNAs%20in%20human%20cancer:%20emerging%20new%20targets%20in%20cancer%20therapy&rft.jtitle=Cancer%20gene%20therapy&rft.au=Karimzadeh,%20Mohammad%20Reza&rft.date=2021-04-01&rft.volume=28&rft.issue=3-4&rft.spage=157&rft.epage=174&rft.pages=157-174&rft.issn=0929-1903&rft.eissn=1476-5500&rft_id=info:doi/10.1038/s41417-020-00210-7&rft_dat=%3Cgale_proqu%3EA659115923%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c539t-1e0e83fcab60b44d1e3e2b6770508774539c9187613953d8bd6f21892f8bced23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2515480002&rft_id=info:pmid/32773776&rft_galeid=A659115923&rfr_iscdi=true